Le Lézard
Classified in: Health
Subject: SVY

NASH (Non-alcoholic Steatohepatitis) Biomarkers Market to Reach $2 Billion by 2025: Increasing Incidence of Chronic Liver Diseases is Expected to Propel Demand in this Market


DUBLIN, August 18, 2017 /PRNewswire/ --

The "NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Analysis By Type, By End-Use (Pharma & CRO Industry, Hospitals, Diagnostic Labs, Academic Research Institutes), And Segment Forecasts, 2014 - 2025" report has been added to Research and Markets' offering.

Research and Markets Logo

The global non-alcoholic steatohepatitis (NASH) biomarkers market is expected to reach USD 2.09 billion by 2025, according to this new report.

Increasing incidence of chronic liver diseases is expected to propel the demand for NASH biomarkers over the forecast period. The National Health and Nutrition Examination Survey recently found that approximately 30% of Nonalcoholic Fatty Liver Diseases (NAFLD) occurred in the U.S. alone. This disease remains undiagnosed, as a liver can remain fatty without any change in its function. However, it can progress into a serious condition, known as nonalcoholic steatosis that may result in liver failure. NASH is characterized by inflammation and irreversible cell death.

Rising demand for non-invasive diagnostic tools for detection of NASH is another driver of market. Traditionally, liver biopsy is performed to diagnose NAFLD and its degenerative condition, that is, NASH. This technique is expensive and invasive in nature. This disadvantage has led to the development of noninvasive and cost-efficient diagnostic techniques such as biomarker tests. It is observed that many key companies spent significantly on research and development activities to introduce novel biomarker tests. These factors are expected to propel NASH biomarkers market in the coming years.


Companies Mentioned

Key Topics Covered:

1 Research Methodology

2. Executive Summary

3. NASH Biomarkers Market Variables, Trends & Scope

4. NASH Biomarkers Market: Type Estimates & Trend Analysis

5. NASH Biomarkers Market: End-use Estimates & Trend Analysis

6. NASH biomarkers Market: Regional Estimates & Trend Analysis, by Type, and End-use

7. Competitive Landscape 

For more information about this report visit https://www.researchandmarkets.com/research/9rl528/nash

Media Contact:

Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

 


These press releases may also interest you

at 10:28
On March 28, 2024, Broncus Medical (02216.HK) (the "Company" or "we" ) announced annual results for FY 2023. In 2023, Broncus Medical earned product sales of US$12.41 million, an increase of 32% compared to the previous year. Of which, total revenue...

at 10:28
In a groundbreaking leap forward in the realm of nutrition and fitness technology, Portions Master announces the launch of its revolutionary app, set to transform the way individuals approach portion control and nutritional tracking....

at 10:21
Highlights of the Annual Results as of December 31, 2023: Revenue reached RMB2,155.6 millionGross profit amounted to RMB738.5 millionAdjusted non-IFRS net loss improved to RMB208.8 million, representing a significant turnaround from a negative...

at 10:17
The life insurance comparison site QuickQuote.com recently published a guide to accidental death and dismemberment (AD&D) insurance. It revealed that some plans cost only $4 a month and provide $100,000 in coverage....

at 10:15
Options Medical Weight Losstm, the nation's premier medical weight loss clinic and provider of medical weight loss solutions, is proud to announce its second clinic in the Metro Atlanta area at 3651 Peachtree Parkway, Suite B. The clinic cordially...

at 10:15
The "MRSA Drugs Market by MRSA Type, Drug Class, Disease Indication, Route of Administration, Distribution Channel, and Region 2024-2032" report has been added to ResearchAndMarkets.com's offering. The global MRSA drugs market size reached US$ 3.8...



News published on and distributed by: